Amalgamated Bank Aadi Bioscience, Inc. Transaction History

Amalgamated Bank

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 23, 2024	SELL	$1.59 - $2.44 $1,380 - $2,117	-868 Reduced 63.36%	502 $1,000
Q4 2023 Feb 06, 2024	SELL	$1.97 - $5.41 $295 - $811	-150 Reduced 9.87%	1,370 $3,000
Q2 2023 Aug 11, 2023	SELL	$6.84 - $8.56 $3,426 - $4,288	-501 Reduced 24.79%	1,520 $10,000
Q1 2023 May 02, 2023	SELL	$6.85 - $13.0 $2,075 - $3,939	-303 Reduced 13.04%	2,021 $15,000
Q3 2022 Nov 09, 2022	BUY	$12.03 - $14.22 $421 - $497	35 Added 1.53%	2,324 $33,000
Q2 2022 Aug 15, 2022	BUY	$11.57 - $17.92 $26,483 - $41,018	2,289 New	2,289 $28,000

12.6M

23.8K

Ticker AADI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 21,016,800
Market Cap $78.4M
Description
Aadi Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes. Its lead drug candidate, FYARRO is a form of sirolimus bound to albumin. Aadi is evaluating FYARRO in cancers with known mTOR pathway activation, ...

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

Stay updated on Amalgamated Bank with notifications on news.